The global Vitamin K2 market will reach to 279.6 million USD by the end of 2028, from the 154.1 million USD in 2021, with a CAGR of 7.7% in the forecast years.
This report focuses on Vitamin K2 volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Vitamin K2 market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China, Japan, India, etc.
Segment Analysis:
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment Analysis:
The research report includes specific segments by region (country), by manufacturers, by Type and by Application. Each type provides information about the production during the forecast period of 2017 to 2028. by Application segment also provides consumption during the forecast period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
By Company
- Gnosis by Lesaffre
- Kappa Bioscience
- Guandong Sungen
- Viridis BioPharma
- IFF Health (Frutarom)
- Vesta Nutra
- GeneFerm Biotechnology
- Shanghai Reson Biotech
- Guangdong Goodscend
- Seebio Biotech
- Kyowa Hakko
Segment by Type
- Vitamin MK-7
- Vitamin MK-4
- Other (MK-9 etc.)
Segment by Application
- Nutrition
- Food and Beverage
Consumption by Region
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Rest of Europe
- South America
- Mexico
- Brazil
- Rest of South America
TABLE OF CONTENTS
1 VITAMIN K2 MARKET OVERVIEW
- 1.1 PRODUCT OVERVIEW AND SCOPE OF VITAMIN K2
- 1.2 VITAMIN K2 SEGMENT BY TYPE
- 1.2.1 GLOBAL VITAMIN K2 SALES GROWTH RATE COMPARISON BY TYPE (2022-2028)
- 1.2.2 VITAMIN MK-7
- 1.2.3 VITAMIN MK-4
- 1.2.4 OTHER (MK-9 ETC.)
- 1.3 VITAMIN K2 SEGMENT BY APPLICATION
- 1.3.1 GLOBAL VITAMIN K2 SALES COMPARISON BY APPLICATION (2022-2028)
- 1.3.2 NUTRITION
- 1.3.3 FOOD AND BEVERAGE
- 1.4 GLOBAL VITAMIN K2 MARKET SIZE ESTIMATES AND FORECASTS
- 1.4.1 GLOBAL VITAMIN K2 REVENUE 2017-2028
- 1.4.2 GLOBAL VITAMIN K2 SALES 2017-2028
- 1.4.3 VITAMIN K2 MARKET SIZE BY REGION: 2017 VERSUS 2021 VERSUS 2028
2 VITAMIN K2 MARKET COMPETITION BY MANUFACTURERS
- 2.1 GLOBAL VITAMIN K2 SALES MARKET SHARE BY MANUFACTURERS (2017-2022)
- 2.2 GLOBAL VITAMIN K2 REVENUE MARKET SHARE BY MANUFACTURERS (2017-2022)
- 2.3 GLOBAL VITAMIN K2 AVERAGE PRICE BY MANUFACTURERS (2017-2022)
- 2.4 MANUFACTURERS VITAMIN K2 MANUFACTURING SITES, AREA SERVED, PRODUCT TYPE
- 2.5 VITAMIN K2 MARKET COMPETITIVE SITUATION AND TRENDS
- 2.5.1 VITAMIN K2 MARKET CONCENTRATION RATE
- 2.5.2 THE GLOBAL 5 LARGEST VITAMIN K2 PLAYERS MARKET SHARE BY REVENUE
- 2.6 MANUFACTURERS MERGERS & ACQUISITIONS, EXPANSION PLANS
3 VITAMIN K2 RETROSPECTIVE MARKET SCENARIO BY REGION
- 3.1 GLOBAL VITAMIN K2 RETROSPECTIVE MARKET SCENARIO IN SALES BY REGION: 2017-2022
- 3.2 GLOBAL VITAMIN K2 RETROSPECTIVE MARKET SCENARIO IN REVENUE BY REGION: 2017-2022
- 3.3 NORTH AMERICA VITAMIN K2 MARKET FACTS & FIGURES BY COUNTRY
- 3.3.1 NORTH AMERICA VITAMIN K2 SALES BY COUNTRY
- 3.3.2 NORTH AMERICA VITAMIN K2 REVENUE BY COUNTRY
- 3.3.3 UNITED STATES
- 3.3.4 CANADA
- 3.4 EUROPE VITAMIN K2 MARKET FACTS & FIGURES BY COUNTRY
- 3.4.1 EUROPE VITAMIN K2 SALES BY COUNTRY
- 3.4.2 EUROPE VITAMIN K2 REVENUE BY COUNTRY
- 3.4.3 GERMANY
- 3.4.4 FRANCE
- 3.4.5 U.K.
- 3.4.6 ITALY
- 3.4.7 RUSSIA
- 3.5 ASIA PACIFIC VITAMIN K2 MARKET FACTS & FIGURES BY REGION
- 3.5.1 ASIA PACIFIC VITAMIN K2 SALES BY REGION
- 3.5.2 ASIA PACIFIC VITAMIN K2 REVENUE BY REGION
- 3.5.3 CHINA
- 3.5.4 JAPAN
- 3.5.5 SOUTH KOREA
- 3.5.6 INDIA
- 3.5.7 AUSTRALIA
- 3.5.8 SOUTHEAST ASIA
- 3.6 LATIN AMERICA VITAMIN K2 MARKET FACTS & FIGURES BY COUNTRY
- 3.6.1 LATIN AMERICA VITAMIN K2 SALES BY COUNTRY
- 3.6.2 LATIN AMERICA VITAMIN K2 REVENUE BY COUNTRY
- 3.6.3 MEXICO
- 3.6.4 BRAZIL
- 3.6.5 ARGENTINA
- 3.7 MIDDLE EAST AND AFRICA VITAMIN K2 MARKET FACTS & FIGURES BY COUNTRY
- 3.7.1 MIDDLE EAST AND AFRICA VITAMIN K2 SALES BY COUNTRY
- 3.7.2 MIDDLE EAST AND AFRICA VITAMIN K2 REVENUE BY COUNTRY
- 3.7.3 TURKEY
- 3.7.4 SAUDI ARABIA
- 3.7.5 UAE
4 VITAMIN K2 HISTORIC MARKET ANALYSIS BY TYPE
- 4.1 GLOBAL VITAMIN K2 SALES MARKET SHARE BY TYPE (2017-2022)
- 4.2 GLOBAL VITAMIN K2 REVENUE MARKET SHARE BY TYPE (2017-2022)
- 4.3 GLOBAL VITAMIN K2 PRICE BY TYPE (2017-2022)
5 VITAMIN K2 HISTORIC MARKET ANALYSIS BY APPLICATION
- 5.1 GLOBAL VITAMIN K2 SALES MARKET SHARE BY APPLICATION (2017-2022)
- 5.2 GLOBAL VITAMIN K2 REVENUE MARKET SHARE BY APPLICATION (2017-2022)
- 5.3 GLOBAL VITAMIN K2 PRICE BY APPLICATION (2017-2022)
6 KEY COMPANIES PROFILED
- 6.1 GNOSIS BY LESAFFRE
- 6.1.1 GNOSIS CORPORATION INFORMATION
- 6.1.2 GNOSIS DESCRIPTION AND BUSINESS OVERVIEW
- 6.1.3 GNOSIS VITAMIN K2 SALES, REVENUE AND GROSS MARGIN (2017-2022)
- 6.1.4 GNOSIS VITAMIN K2 PRODUCT PORTFOLIO
- 6.1.5 GNOSIS RECENT DEVELOPMENTS/UPDATES
- 6.2 KAPPA BIOSCIENCE
- 6.2.1 KAPPA BIOSCIENCE CORPORATION INFORMATION
- 6.2.2 KAPPA BIOSCIENCE DESCRIPTION AND BUSINESS OVERVIEW
- 6.2.3 KAPPA BIOSCIENCE VITAMIN K2 SALES, REVENUE AND GROSS MARGIN (2017-2022)
- 6.2.4 KAPPA BIOSCIENCE VITAMIN K2 PRODUCT PORTFOLIO
- 6.2.5 KAPPA BIOSCIENCE RECENT DEVELOPMENTS/UPDATES
- 6.3 GUANDONG SUNGEN
- 6.3.1 GUANDONG SUNGEN CORPORATION INFORMATION
- 6.3.2 GUANDONG SUNGEN DESCRIPTION AND BUSINESS OVERVIEW
- 6.3.3 GUANDONG SUNGEN VITAMIN K2 SALES, REVENUE AND GROSS MARGIN (2017-2022)
- 6.3.4 GUANDONG SUNGEN VITAMIN K2 PRODUCT PORTFOLIO
- 6.3.5 GUANDONG SUNGEN RECENT DEVELOPMENTS/UPDATES
- 6.4 VIRIDIS BIOPHARMA
- 6.4.1 VIRIDIS BIOPHARMA CORPORATION INFORMATION
- 6.4.2 VIRIDIS BIOPHARMA DESCRIPTION AND BUSINESS OVERVIEW
- 6.4.3 VIRIDIS BIOPHARMA VITAMIN K2 SALES, REVENUE AND GROSS MARGIN (2017-2022)
- 6.4.4 VIRIDIS BIOPHARMA VITAMIN K2 PRODUCT PORTFOLIO
- 6.5 IFF HEALTH (FRUTAROM)
- 6.5.1 FRUTAROM CORPORATION INFORMATION
- 6.5.2 FRUTAROM DESCRIPTION AND BUSINESS OVERVIEW
- 6.5.3 FRUTAROM VITAMIN K2 SALES, REVENUE AND GROSS MARGIN (2017-2022)
- 6.5.4 FRUTAROM VITAMIN K2 PRODUCT PORTFOLIO
- 6.6 VESTA NUTRA
- 6.6.1 VESTA NUTRA CORPORATION INFORMATION
- 6.6.2 VESTA NUTRA DESCRIPTION AND BUSINESS OVERVIEW
- 6.6.3 VESTA NUTRA VITAMIN K2 SALES, REVENUE AND GROSS MARGIN (2017-2022)
- 6.6.4 VESTA NUTRA VITAMIN K2 PRODUCT PORTFOLIO
- 6.7 GENEFERM BIOTECHNOLOGY
- 6.7.1 GENEFERM BIOTECHNOLOGY CORPORATION INFORMATION
- 6.7.2 GENEFERM BIOTECHNOLOGY DESCRIPTION AND BUSINESS OVERVIEW
- 6.7.3 GENEFERM BIOTECHNOLOGY VITAMIN K2 SALES, REVENUE AND GROSS MARGIN (2017-2022)
- 6.7.4 GENEFERM BIOTECHNOLOGY VITAMIN K2 PRODUCT PORTFOLIO
- 6.8 SHANGHAI RESON BIOTECH
- 6.8.1 SHANGHAI RESON BIOTECH CORPORATION INFORMATION
- 6.8.2 SHANGHAI RESON BIOTECH DESCRIPTION AND BUSINESS OVERVIEW
- 6.8.3 SHANGHAI RESON BIOTECH VITAMIN K2 SALES, REVENUE AND GROSS MARGIN (2017-2022)
- 6.8.4 SHANGHAI RESON BIOTECH VITAMIN K2 PRODUCT PORTFOLIO
- 6.9 GUANGDONG GOODSCEND
- 6.9.1 GUANGDONG GOODSCEND CORPORATION INFORMATION
- 6.9.2 GUANGDONG GOODSCEND DESCRIPTION AND BUSINESS OVERVIEW
- 6.9.3 GUANGDONG GOODSCEND VITAMIN K2 SALES, REVENUE AND GROSS MARGIN (2017-2022)
- 6.9.4 GUANGDONG GOODSCEND VITAMIN K2 PRODUCT PORTFOLIO
- 6.10 SEEBIO BIOTECH
- 6.10.1 SEEBIO BIOTECH CORPORATION INFORMATION
- 6.10.2 SEEBIO BIOTECH DESCRIPTION AND BUSINESS OVERVIEW
- 6.10.3 SEEBIO BIOTECH VITAMIN K2 SALES, REVENUE AND GROSS MARGIN (2017-2022)
- 6.10.4 SEEBIO BIOTECH VITAMIN K2 PRODUCT PORTFOLIO
- 6.11 KYOWA HAKKO
- 6.11.1 KYOWA HAKKO CORPORATION INFORMATION
- 6.11.2 KYOWA HAKKO DESCRIPTION AND BUSINESS OVERVIEW
- 6.11.3 KYOWA HAKKO VITAMIN K2 SALES, REVENUE AND GROSS MARGIN (2017-2022)
- 6.11.4 KYOWA HAKKO VITAMIN K2 PRODUCT PORTFOLIO
7 VITAMIN K2 MANUFACTURING COST ANALYSIS
- 7.1 VITAMIN K2 KEY RAW MATERIALS ANALYSIS
- 7.1.1 KEY RAW MATERIALS
- 7.1.2 KEY SUPPLIERS OF RAW MATERIALS
- 7.2 PROPORTION OF MANUFACTURING COST STRUCTURE
- 7.3 MANUFACTURING PROCESS ANALYSIS OF VITAMIN K2
- 7.4 VITAMIN K2 INDUSTRIAL CHAIN ANALYSIS
8 MARKETING CHANNEL, DISTRIBUTORS AND CUSTOMERS
- 8.1 MARKETING CHANNEL
- 8.2 VITAMIN K2 DISTRIBUTORS LIST
- 8.3 VITAMIN K2 CUSTOMERS
9 VITAMIN K2 MARKET DYNAMICS
- 9.1 VITAMIN K2 INDUSTRY TRENDS
- 9.2 VITAMIN K2 MARKET DRIVERS
- 9.3 VITAMIN K2 MARKET CHALLENGES
- 9.4 VITAMIN K2 MARKET RESTRAINTS
10 GLOBAL MARKET FORECAST
- 10.1 VITAMIN K2 MARKET ESTIMATES AND PROJECTIONS BY TYPE
- 10.1.1 GLOBAL FORECASTED SALES OF VITAMIN K2 BY TYPE (2023-2028)
- 10.1.2 GLOBAL FORECASTED REVENUE OF VITAMIN K2 BY TYPE (2023-2028)
- 10.2 VITAMIN K2 MARKET ESTIMATES AND PROJECTIONS BY APPLICATION
- 10.2.1 GLOBAL FORECASTED SALES OF VITAMIN K2 BY APPLICATION (2023-2028)
- 10.2.2 GLOBAL FORECASTED REVENUE OF VITAMIN K2 BY APPLICATION (2023-2028)
- 10.3 VITAMIN K2 MARKET ESTIMATES AND PROJECTIONS BY REGION
- 10.3.1 GLOBAL FORECASTED SALES OF VITAMIN K2 BY REGION (2023-2028)
- 10.3.2 GLOBAL FORECASTED REVENUE OF VITAMIN K2 BY REGION (2023-2028)
11 RESEARCH FINDINGS AND CONCLUSION
12 METHODOLOGY AND DATA SOURCE
- 12.1 METHODOLOGY/RESEARCH APPROACH
- 12.1.1 RESEARCH PROGRAMS/DESIGN
- 12.1.2 MARKET SIZE ESTIMATION
- 12.1.3 MARKET BREAKDOWN AND DATA TRIANGULATION
- 12.2 DATA SOURCE
- 12.2.1 SECONDARY SOURCES
- 12.2.2 PRIMARY SOURCES
- 12.3 AUTHOR LIST
- 12.4 DISCLAIMER 93'